| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |